Tissue Regenix Group Investor Relations Material
Latest events
H1 2024
10 Sep, 2024
H2 2023
19 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tissue Regenix Group plc
Access all reports
Tissue Regenix Group plc is a UK-based regenerative medical devices company. It develops and commercializes biological implants and tissue-based products for use in orthopedics, wound care, and dental applications. Its patented decellularization technology processes human and animal tissue for safe and effective transplant use. The company is headquartered in Leeds, United Kingdom, and its shares are listed on the LSE.
Key slides for Tissue Regenix Group plc
H1 2024
Tissue Regenix Group plc
H1 2024
Tissue Regenix Group plc
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
TRX
Country
🇬🇧 United Kingdom